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Abstract 
 
Polymer-based composite materials have replaced the use of amalgam as filling material of 
choice in modern dentistry. Methacrylate monomers are key constituents in the polymer-based 
composite materials. The monomers are found to be airborne in dental practices, making airway 
exposure likely. Human bronchial epithelial cells, BEAS-2B, were therefore used as an in vitro 
model system.  
Methacrylate monomers have been associated with cell growth disturbances, glutathione 
depletion, DNA damage and cell death in different human cell lines. The detailed cellular 
mechanisms underlying these effects are still unclear. Oxidative stress caused by glutathione 
depletion is suggested as a possible mechanism in the development of cytotoxic effects. 
However, resent findings indicate other mechanisms to be of importance.  
In the current study, the mechanisms involved in the cellular response to the two commonly used 
methacrylate monomers glycerol dimethacrylate (GDMA) and 2-hydroxyethyl methacrylate 
(HEMA) were investigated. The main focus was to map DNA damage response and the 
involvement of glutathione depletion. In order to investigate the role of glutathione depletion and 
oxidative stress, the effect of the monomers were compared to two glutathione depleting agents, 
diethyl maleate (DEM) and buthionine sulfoximine (BSO).  
Glutathione depletion, oxidative stress, cell cycle disturbances and DNA damage were observed 
in BEAS-2B cells following exposure to both GDMA and HEMA. Similar effects on glutathione 
depletion and increased oxidative stress were seen in the two exposure scenarios. The effects on 
cell growth, cyclin levels and activation of DNA damage signalling proteins differed between the 
monomers, indicating differences in cellular response mechanisms. The results show that 
oxidative stress caused by glutathione depletion cannot alone explain the monomer-induced 
cytotoxicity in vitro.  
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1 Introduction 
 
1.1 Biomaterials 
Biomaterials are synthetic materials used for replacement of a part or a function of the body, with 
the ultimate goal of improving human heath [1]. Disease or trauma may cause the need for 
artificial heart valves, cochlear implants, joint replacements or dental restorations. These are all 
some examples of biomaterials used in medicine today. 
The important challenge regarding biomaterials is that they are designed to replace living tissue 
that has had millions of years of evolution to adapt to their unique role and function [2]. 
Biomaterials need therefore to be structurally and functionally compatible and function as a 
substitute for the body part it has replaced.  
The term biocompatibility refers to a materials ability to perform its desired functions, without 
causing unwanted biological effects in the recipient [3]. An evaluation of biocompatibility 
includes a number of scientific fields including cell biology, toxicology, medicine and physics. 
The potential risk of unwanted biological effects when using biomaterials makes biocompatibility 
related to risk assessment [4]. The challenge is to develop biomaterials with qualities that 
outweigh the potential risks. The precautionary principle and the risk of health effects make the 
field of biomaterials dynamic with a constant potential for improvements. Research on the 
biological effects of these materials therefore results in improvement of their quality and lead to 
progression of the field of biomaterials.  
 
1.2 Dental biomaterials 
For about 150 years, the restorative material amalgam has been the dental filling material of 
choice, and in some parts of the world, it still is [5]. Amalgam is a metal alloy consisting of about 
50% mercury (Hg) in addition to silver (Ag), tin (Sn) and copper (Cu) [6]. Mercury can be very 
toxic to humans, affecting the central nervous system, the gastrointestinal tract and the respiratory 
system [7]. It is also considered an environmental pollutant [8]. Because it is nonbiodegradable it 
12 
 
can potentially bioaccumulate in aquatic and terrestrial organisms once released into the 
environment.   
It was the growing concern about mercury as an environmental pollutant that made Norway issue 
a ban of all the use, production and import of mercury in 2008 [9]. Amalgam is affected by this 
ban, and can therefore no longer be used as a dental restorative material. A more esthetical 
alternative to amalgam is the polymer-based composite filling materials [5]. In general, 
composite materials are composed of two or more components to produce a product that has 
properties exceeding the individual components on their own [4].  
Polymer-based composite filling materials consists of three main components [4], a polymer 
matrix, filler particles, and coupling agents. The polymer matrix is composed of methacrylate 
monomers bound together to form strong polymer structures. The polymer matrix is reinforced 
with filler particles to increase physical and mechanical properties of the material. To approve the 
binding between the polymer matrix and the filler particles, coupling agents are used. Polymer-
based composite materials comprise several types of filling materials such as compomeres, 
adhesives and polymer-based glassionomers. For simplicity, these materials are referred to as 
composite filling materials throughout this thesis.  
 
1.3 Chemistry of methacrylate monomers 
A polymer is a large molecule composed of repeated units called monomers bound together in 
chains and by cross-linking (fig. 1). To form this polymer matrix, monomers are linked together 
in a polymerization reaction. Methacrylate monomers such as glycerol dimethacrylate (GDMA) 
and 2-hydroxyethyl methacrylate (HEMA) (fig. 2) are used as precursors to form the polymer 
matrix in composite filling materials. The reactive part of the monomer is the electrophilic carbon 
resulting from the carbon-carbon double bond in the carboxylic ester group (methacrylate group). 
HEMA, being a mono-methacrylate, have one methacrylate group (one electrophilic carbon), 
while GDMA is a di-methacrylate and have two methacrylate groups (two electrophilic carbons).  
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Figure 1. Illustration of the polymerization process  
 
 
Figure 2. a) Glycerol dimethacrylate (GDMA)  and b) 2-hydroxyethyl methacrylate (HEMA)   
 
The polymerization reaction is dependent on monomers ability to form free radicals [4]. To start 
the reaction a free radical is needed as an initiator, this can be introduced by chemical agents, 
heat or via light activation. The free radical can react with a monomer molecule by extracting an 
electron from their double bond, leaving the other electron of the double bond unpaired. This 
forms a new free radical site in the molecule, and the reaction is initiated. The reaction continues 
adding monomers to the growing polymer chain, until the reaction is terminated. Termination can 
occur because of a combination between two growing polymer chains or the transfer of a 
hydrogen atom to another polymer. 
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Methacrylate monomers have different chemical properties, but they all have at least one 
carboxylic ester group (methacrylate group), conjugated with a double bond between the α- and 
the β-carbon. This is the reactive part of the molecule during polymerization. The double bond 
between the two carbon atoms results in an electrophilic β-carbon [10, 11]. Electrophilic 
chemicals can react and bind to endogenous molecules that have a nucleophilic carbon such as 
glutathione, DNA and proteins. 
The degree of conversion reflects the percentage of methacrylate double bonds that have reacted 
during polymerization [4]. The degree of conversion rarely exceeds 75 % [12]. This can result in 
release of unpolymerized monomers after placement of the dental materials [13].  
 
1.4 Exposure to methacrylate monomers 
Both dental personnel and patients are exposed to components of dental materials [13-17], but the 
extent and the severity is not fully known. Major absorption routes for foreign chemicals are 
through the skin, gastrointestinal tract and the lungs, depending on the nature of the chemical and 
the exposure situation.   
After restorative treatment, measurable amounts of methacrylate monomers have been detected in 
salvia of the patients [13], where the monomers can interact locally or reach the gastrointestinal 
tract. Monomers are also present in the air of dental practices [15, 16], making exposure through 
the lungs a possible absorption route for both personnel and patients during the handling of 
composite filling materials. Upon inhalation, chemicals can diffuse into the bloodstream. 
Compounds that reach the bloodstream can then be transported rapidly throughout the body [4, 
7].  
The skin is the largest organ in the human body and functions as a relatively impermeable barrier 
against foreign substances. Many chemicals can despite of this penetrate the skin and cause local 
and possibly systemic effects. Published studies on allergic contact dermatitis and allergy in 
dental personnel [18, 19], demonstrates that methacrylate monomers can be absorbed through the 
skin and cause allergic effects. Due to degradation of the materials over time, long-term exposure 
may also be of relevance for the in vivo situation [17].  
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1.5 Toxic responses 
The biological responses to foreign chemicals are many and variable. Chemical structure and 
properties, exposure dose and duration will influence the response. Toxicity can be local or 
systemic, reversible or irreversible, immediate or delayed [20].  
Development of toxicity usually involves a reaction between the ultimate toxicant and a target 
molecule [20]. By interacting with molecules with different roles, the toxicant produces effects 
that can impair several functions in a cell. Insufficient repair or inappropriate adaptation to 
damaging agents can lead to inflammation, DNA damage, dysregulation of the cell cycle and cell 
death [7].  
 
1.5.1 Cell death 
There are two main morphological changes seen in dying cells (fig. 3); apoptotic cells undergo 
shrinkage and condensation of the chromosomes, while necrotic cells swell and rupture, causing 
inflammation and damage to the surrounding tissue [7]. Apoptosis is a form of programmed cell 
death, where the cell initiates a process that eventually leads to the phagocytosis of the damaged 
cell by macrophages and other phagocytes [21]. This prevents damage to the surrounding tissue.  
Apoptosis is a natural part of the maintenance and renewal of tissues, but it can also be a response 
to a toxicant. More acute damage to cells might result in necrosis. Necrotic cell death can be 
described as a chaotic process characterized by the rupture of membranes, dissolution of 
organelles and loss of homeostasis and ATP [7]. Some toxicants have a tendency to induce 
apoptosis at low concentrations, but when the dose and exposure time increases, the cells become 
energy depleted and necrosis is the only possible outcome [20, 22]. 
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Figure 3. Morphological changes seen in cells during apoptotic and necrotic cell death. Figure from [23] 
 
 
1.5.2 Oxidative stress 
Reactive oxygen species (ROS) are free radicals containing oxygen atoms, like superoxide anion 
(O2
-), hydrogen peroxide (H2O2) and hydroxyl radicals (HO·). They are highly reactive because 
of their unpaired electrons. ROS are natural by-products of oxygen metabolism, but they are toxic 
to cells if present in excessive amounts. Toxicants are also able to increase levels of ROS in cells, 
directly or indirectly [20].   
To protect itself from the damaging effects of ROS, cells have protective molecules called 
antioxidants. Ascorbic acid (vitamin C), carotenes (β-carotene, retinol) and glutathione (GSH) are 
all antioxidants that protect cells from oxidative damage. GSH is an important antioxidant in the 
human defence system, and is found in most cells with the highest concentration occurring in the 
liver (5mM or more) [7], reflecting this organs role in detoxification of toxicants. If a toxic 
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substance depletes the cells of its GSH content, it can lead to increased levels of ROS, this 
situation is known as oxidative stress (fig. 4) [7]. Oxidative stress can lead to lipid peroxidation, 
protein damage and DNA strand breaks, cell injury and/or cell death [20].  
 
 
Figure 4. Oxidative stress is associated with a depletion of antioxidants or an excess of ROS 
 
In addition to being an abundant antioxidant, glutathione also have a role in metabolism of 
toxicants (detoxification). The goal is to reduce toxicity and facilitate excretion. In phase 1 
metabolism, a polar or reactive chemical group is added to toxicants by enzymes such as the 
cytochrome P450 oxidases [7]. Phase 2 metabolism involves conjugation between endogenous 
chemicals and toxicant. Glutathione conjugation is an important phase 2 reaction in detoxification 
[7], both due to the reactivity towards electrophilic molecules and because of the high 
concentrations of glutathione in cells. Because of the nucleophilic SH-group, it can react with 
electrophilic molecules making them more polar (and more water-soluble) which will facilitate 
excretion. 
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1.5.3 DNA damage and cell cycle regulation 
The DNA molecule contains all the genetic information in organisms, and encodes all the 
molecules that are synthesized in the cells. DNA damage is any kind of change in the DNA 
molecule and can be the result of exposure to different chemicals and radiation. When a cell 
divides, it copies its genome, and passes one copy to each of the two daughter cells that are 
produced. DNA damage that is not repaired can result in mutations that can lead to genetic 
diseases because of dysfunctional or non-functional proteins. Mutations can ultimately lead to the 
formation of a tumour that can develop into cancer. The number and severity of inheritable 
human diseases that have been linked with defects in DNA repair processes, show how important 
it is for cells to repair any damaged DNA [24].   
 
 
 
Figure 5. DNA damage starts signalling cascades that eventually results in cell cycle control, cell death or DNA-repair. Modified 
figure from PhD thesis by Ansteinsson [25] 
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Sensor proteins guarding the DNA can recognize damage and initiate signalling pathways via 
transducers to effector proteins (fig. 5). The effector proteins activate DNA repair processes or 
eliminate the cell via apoptosis if the damage is beyond repair [26]. One of the more serious 
forms of DNA damage is a double strand break, because this will destroy the double helical 
structure of the DNA molecule, making DNA repair more difficult. Single strand breaks are not 
as critical because the double helix stays intact [24, 27]. The cell response to double strand breaks 
involves activation of signalling cascades via the sensor proteins ataxia telangiectasia mutated 
(ATM) [27] and H2AX (activated form is known as γH2AX) [28]. ATM further activates, via 
phosphorylation, several transducer and effector proteins that can regulate DNA damage 
checkpoints in the cell cycle. Proteins that are phosphorylated as a part of this signalling cascade 
include P53 [29] and Chk2 [30]. P53 has multiple roles in cell signalling and is activated by 
several stressors. Different forms of DNA damage are able to activate P53, which leads to an 
increase in cell concentration of pP53 that is proportional to the amount of DNA damage [29]. 
DNA damage checkpoints ensure that a cell enters some form of cell cycle arrest to repair 
damaged DNA before replication and cell division. Cyclin-dependent kinases (CDKs) and 
proteins known as cyclins regulate progression through the cell cycle. The CDKs are catalytic 
subunits of an effective enzyme, and the enzyme is not active unless bound to the regulatory 
subunit, the cyclins. The CDKs activity is controlled through phosphorylation, by inhibitory 
proteins and by the availability of the cyclins [31].  
 
 
 
 
 
 
20 
 
1.6 Toxicity of methacrylate monomers 
Both in vivo and in vitro studies have identified toxic responses to composite filling materials 
[32]. Dental personnel are known to suffer occupational dermatitis and skin diseases following 
contact with reactive chemicals from dental materials [33, 34]. It has also been rapports on 
contact allergy and dermatitis related specially to methacrylate monomer exposure [18, 19].  
Most studies on the toxicity of methacrylate monomers are conducted in vitro, and one of the 
most studied monomer is HEMA. Methacrylate monomers are cytotoxic and they are able to 
induce cell death in different human cell lines [35-39]. Cell cycle arrest and DNA damage is 
indicated after in vitro exposure to HEMA [40, 41]. The mechanisms behind the cytotoxicity are 
however unclear. 
Adduct formation with glutathione (GSH) have been suggested as a main mechanism in 
methacrylate monomer induced cytotoxicity [36, 37, 39, 42]. Both GDMA and HEMA have been 
shown to form adducts with and thereby deplete the cellular content of GSH in cells [10, 43]. 
This will lower the cells ability to counteract oxidative damage, and possibly lead to oxidative 
stress. Oxidative stress can then be the initial event causing apoptosis, cell cycle arrest and DNA 
damage. The monomers ability to deplete GSH seem, however, not to correspond to their 
cytotoxic potential [10]. Additional mechanisms are therefore likely to be involved in the cellular 
response to methacrylate monomers.  
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1.7 Aims  
 
The working hypothesis of this study was that the methacrylate monomers GDMA and HEMA 
induce DNA damage by different cellular mechanisms.  
The specific aim was to study and compare cellular mechanisms in response to GDMA and 
HEMA exposure. This involved to:  
 Investigate glutathione and oxidative stress in the cellular response after exposure 
 Investigate DNA damage signalling pathways and responses after exposure 
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2 Materials 
 
2.1 Chemicals and antibodies 
 
Table 1. List of chemicals 
Chemicals (CAS no.) 
Product 
number 
Manufacturer 
2-Hydroxyethyl methacrylate (HEMA) (868-
77-9) 
64166 Sigma-Aldrich, St. Louis, USA 
2,7-dichlorofluorescein diacetate (DCFH-DA) 
(4091-99-0) 
D6883 Sigma-Aldrich, St. Louis, USA 
2-Mercaptoethanol (60-24-2) M6250 Sigma-Aldrich, St. Louis, USA 
30 % Acrylamide/Bis Solution  161-0158 Bio-Rad Laboratories, Inc., CA, USA 
Ammonium persulfate (APS) (7727-54-0) A3678 Sigma-Aldrich, St. Louis, USA 
Annexin V-FITC Apoptosis Detection Kit BMS500FI 
Bender MedSystems GmbH, Vienna, 
Austria 
Bovine collagen solution (9007-34-5) 5005-B 
Advanced Biomatrix, INAMED corp., 
Fremont, USA 
Bovine serum albumin (BSA) (9048-46-8) A7906 Sigma-Aldrich, St. Louis, USA 
Bromophenol blue sodium salt (62625-28-9) B8026 Sigma-Aldrich, St. Louis, USA 
Buthionine sulfoximine (BSO) (83730-53-4) B2515 Sigma-Aldrich, St. Louis, USA 
Diethyl maleate (DEM) (141-05-9) W505005 Sigma-Aldrich, St. Louis, USA 
Dimethyl sulphoxide (DMSO) (67-68-5) 116743 Merck KGaA, Darmstadt, Germany 
Fetal bovine serum (FBS) F4135 Sigma-Aldrich, St. Louis, USA 
Gibco LHC-9 cell medium 12680-013 
Invitrogen-Life Technologies, CA, 
USA 
Glycerol 85% (56-81-5) 104094 Merck KGaA, Darmstadt, Germany 
Glycerol-dimethacrylate (GDMA) (1830-78-0) 436895 Sigma-Aldrich, St. Louis, USA 
Glycine (56-40-6) G7126 Sigma-Aldrich, St. Louis, USA 
Hepes Buffered Saline Solution (HEPES buffer) CC-5024 Lonza, Verviers, Belgium 
Hoechst 33342 (23491-52-3) B2261 Sigma-Aldrich, St. Louis, USA 
Methanol (67-56-1) 106007 Merck KGaA, Darmstadt, Germany 
Molecular weight marker 928-40000 LiCor Biosciences, Hamburg, Germany 
Monobromobimane (71418-44-5) 69898 Sigma-Aldrich, St. Louis, USA 
MTT solution (Thiazolyl Blue Tetrazolium 
Bromide) (298-93-1) 
M2128 Sigma-Aldrich, St. Louis, USA 
N-Ethylmaleimide (NEM) (128-53-0) E3876 Sigma-Aldrich, St. Louis, USA 
Nuclear isolations and staining solution (NIM-
DAPI) 
731085 NPE Systems, Florida, USA 
Phosphate buffered saline (PBS) BE17-516F Lonza, Verviers, Belgium 
Ponceau S (6226-79-5) P-3504 Sigma-Aldrich, St. Louis, USA 
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Propidium iodide solution (PI) (25535-16-4) 70335 Sigma-Aldrich, St. Louis, USA 
Sodium chloride (NaCl) (7647-14-5) S5886 Sigma-Aldrich, St. Louis, USA 
Sodium dodecyl sulfate (SDS) (151-21-3) L4390 Sigma-Aldrich, St. Louis, USA 
Sucrose (57-50-1) 10274 Analar, BDH Middle East LLC, Dubai 
Tetramethylethylenediamine (TEMED) (110-
18-9) 
T9281 Sigma-Aldrich, St. Louis, USA 
Tricine (5704-04-1) T5816 Sigma-Aldrich, St. Louis, USA 
tri-Natriumcitrat-2-hydrat (tri-sodiumcitrat) 
(6132-04-3) 
106448 Merck KGaA, Darmstadt, Germany 
Trizma base (77-86-1) T1503 Sigma-Aldrich, St. Louis, USA 
Trypsin/EDTA solution (9002-07-7) CC-5012 Lonza, Verviers, Belgium 
Tween 20 (9005-64-5) 822184 Merck KGaA, Darmstadt, Germany 
Virkon 1232-8667 
Antec Int.-A Du Pont Comp., Suffolk, 
UK 
 
Table 2. Antibodies 
Antibodies Product number Manufacturer 
β-actin 4967 Cell signaling Technology, Inc., USA 
Phospho-p53 (Ser15) 9284 Cell signaling Technology, Inc., USA 
Phospho-Chk2 (Thr68) 2661 Cell signaling Technology, Inc., USA 
Phospho-Histone H2A.X (Ser139) 2577 Cell signaling Technology, Inc., USA 
Cyclin D1 (92G2) 2978 Cell signaling Technology, Inc., USA 
Cyclin E1 (HE12) 4129 Cell signaling Technology, Inc., USA 
Goat anti-mouse IgG, secondary Ab 926-32210 LiCor Biosciences, Hamburg, Germany 
Goat anti-rabbit IgG, secondary Ab 926-68071 LiCor Biosciences, Hamburg, Germany 
 
 
2.2 Equipment and software 
 
Table 3. Equipment and software 
Equipment and software Manufacturer 
Accuri C6 Flow Cytometer BD Bioscience, Bedford, MA, USA 
Aerosol Resistant Tips (ART) pipette tips Molecular Bio Products, USA 
Autoclave (HV-50L) Hirayama, Hong Kong 
Bürker counting chamber Assistant, Sondheim, Germany 
Cell culture flasks BD Falcon, Bedford, MA, USA 
Cell Lab Quanta SC Flow Cytometer Beckman Coulter, Florida, USA 
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CO₂ incubator (SANYO MCO-18AIC(UV)) Surplus Solutions, LLC, USA 
Costar plates Corning Incorporated, NY, USA 
Electrophoresis systems and blotting module TetraCell, Bio-Rad Inc., CA, USA 
GraphPad Prism 4 software GraphPad Software, CA, USA 
Image Studio software LiCor Biosciences, Hamburg, Germany 
Micropipettes Sarstedt, Nümbrecht, Germany 
Multicycle  Phoenics Flow Systems, CA, USA 
Odyssey CLx Western blot scanner LiCor Biosciences, Hamburg, Germany 
Olympus BX51 fluorescence microscope Olympus Europe, Hamburg, Germany 
Olympus C7070 camera Olympus Europe, Hamburg, Germany 
Olympus CKX41 inverted phase contrast microscope Olympus Europe, Hamburg, Germany 
Olympus DP70 camera Olympus Europe, Hamburg, Germany 
Rotina 35R Centrifuge Hettich, Tuttlingen, Germany 
SensION pH31, pH meter Hach Company, Colorado, USA 
Synergy H1 Spectrophotometric plate reader BioTek Instruments Inc., Vermont, USA 
 
 
2.3 Buffers and gels 
 
Table 4. Sample buffer, gel buffer and TBS buffer 
Chemicals Sample buffer Gel buffer 5x TBS buffer  
Trizma base 1.817 g 90.75 g 30.3 g 
Glycine       
Glycerol 85 % 30 g     
SDS 12 g     
NaCl     43.8 g 
Distilled water   250 mL 1000 mL 
pH Adjust to 7.0 Adjust to 8.46 Adjust to 7.5 
  Adjust final volume      
  to 100 mL with dest.water     
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Table 5. Anode buffer, cathode buffer and transfer buffer 
Chemicals 10x Anode-buffer 10x Cathode-buffer 10x Transfer buffer 
Trizma base 60.57 g  60.57 g  30.3 g 
Glycine     144.1 g 
Tricine   89.59 g    
SDS   5 g   
Distilled water 500 mL 500 mL 800 mL 
pH Adjust to 8.9 Adjust to 8.25 Do not adjust! 
      Adjust final volume  
      to 1000 mL with dest.water 
 
Table 6. Separating gel and stacking gel 
Chemicals Tricine separating gel (16 %) Stacking gel (4 %) 
30 % Acrylamide/Bis solution 16 mL 1.6 mL 
Gel buffer 10 mL 3 mL 
Glycerol 85 % 3.5 g   
Distilled water Ad 30 mL Ad 12 mL 
10 % SDS 300 µL 90 µL 
10 % APS 100 µL 90 µL 
TEMED 10 µL 10 µL 
 
Table 7. Citrate buffer 
Chemicals Citrate buffer 
Sucrose 85.5 g 
Tri-sodiumcitrate 11.8 g 
DMSO 50 mL 
Distilled water Ad 1000 mL 
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3 Methods 
 
3.1 Cell line 
Human bronchial epithelial cells, BEAS-2B, is an adenovirus (12-SV40 hybrid) transformed cell 
line [44]. The cell line is available from European Tissue Type Culture Collection (ECACC) and 
distributed by Sigma-Aldrich. The cells are cultured in serum-free cell culture medium, LHC-9, 
formulated for the growth of bronchial epithelial cells in vitro. BEAS-2B is classified as a 
biosafety level 2 cell line (Material safety sheet, 2009).  
 
Figure 6. Phase contrast microscopy picture of BEAS-2B cells 
 
3.1.1 Treatment of cells 
Cells were cultivated in sterile cell culture flasks and kept in an incubator under stable conditions 
(37 °C, 5 % CO₂, > 95 % relative humidity). BEAS-2B is an adherent cell line. Culture flasks 
and -plates were pre-coated with collagen (30 µg/ml in Hepes buffer) before plating the cells. The 
cells were monitored daily by phase contrast microscopy. When the cells were 80 – 85 % 
confluent, they were diluted 1:5 and transferred to a new flask for further growth. Medium was 
changed 24 hours after dilution. Trypsin was used to detach cells from the coating surface. 
Trypsin is a proteolytic enzyme, which breaks down the proteins that binds the cells to the 
surface, and dissociates adherent cells from the coating. Medium, trypsin and other solutions 
were preheated to 37 °C before added to the cells.  
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Cells that were not used were discarded in 2 % Virkon solution. Equipment that had been in 
contact with the cells was sterilized using an autoclave (121 °C, 60 min).  
 
3.1.2 Seeding and exposure of cells 
Twenty-four hours before the start of an experiment, cells were counted in a Bürker counting 
chamber and transferred onto pre-coated plates for cell growth (25 000 cells/cm²). Medium was 
changed one hour before the cells were exposed.  
Stock solutions of GDMA (2 mM), HEMA (200 mM), buthionine sulfoximine (BSO) (2.5 mM) 
and diethyl maleate (DEM) (6 mM) were prepared fresh before every experiment by diluting the 
respective substances in cell medium. A calculated volume of the stock solutions was added to 
the cell culture to obtain the final exposure concentrations.   
 
3.2 MTT assay 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay measures the 
activity of succinate-dehydrogenase (SDH) enzymes in cells [45]. SDH-enzymes in living cells 
reduce the yellow MTT substrate to a blue formazan product (fig. 7). The amount of formazan 
product therefore reflects the SDH-activity and viability in the cell cultures. The SDH-activity is 
assessed by measuring absorption using a spectrophotometer at a wavelength of 570 nm. MTT is 
a commonly used assay to assess cell viability in cytotoxicity studies, and is applied to many 
different cell cultures [46-48].  
 
 
Figure 7. MTT is reduced to formazan by mitochondrial SDH-enzymes in living cells. Figure from Mao Z et al. [49]  
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Procedure: 
 Medium is replaced with 500 µl MTT solution (0.5 mg/ml PBS)  
 1 hour incubation (37 ˚C, 5 % CO₂, > 95 % relative humidity) 
 MTT solution is removed 
 500 µl dimethyl sulphoxide (DMSO) is added to dissolve the formazan  
 The plate is shaken for 10 min  
 Absorbance at 570 nm is red on a spectrophotometer 
 
3.3 Fluorescence microscopy 
Changes in cellular morphology can be visualized by staining cellular compartments with 
fluorochromes and looking at the cells in a fluorescence microscope. Hoechst 33342 and 
propidium iodide (PI) are fluorochromes that bind DNA. Hoechst 33342 can penetrate intact cell 
membranes and gives blue fluorescence, while PI does not penetrate cell membranes and gives 
red fluorescence. Viable cells will be stained blue by Hoechst 33342 evenly throughout the 
nucleus. Apoptotic cells will be stained more intense with Hoechst 33342, because of their 
condensed chromosomes. Necrotic cells will lack membrane integrity and therefore be stained 
red with PI.  
 
 
Figure 8. Fluorescence microscopy picture of typical viable, apoptotic and necrotic cells stained with Hoechst 33342 and PI  
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Procedure: 
 The cells and medium are centrifuged (250 g, 4 ˚C, 10 min) and the supernatant is 
removed 
 30 minutes incubation in room temperature (protected from light) with 50 µl FBS with 
Hoechst 33342 (10 µg/ml) and PI (5 µg/ml)  
 One drop of the cell solution is spread out on a microscope slide. The slide is left to dry in 
the dark 
 The slide is studied in a fluorescence microscope (excitation filter 340 – 380 nm)  
 300 cells are counted in each sample 
 
3.4 Flow cytometry 
Flow cytometry is a technique used to analyse characteristics of individual cells. A flow 
cytometer obtains information about each cell by measuring light scatter and fluorescence that the 
cells emit as they flow through a light source, usually a laser or a UV-lamp [50]. Information 
such as DNA content, cell size, viability and cell death on a single cell level can be obtained. In 
addition, this technic can be used to sort cells in a mixture based on different cell surface 
markers.  
 
3.4.1 Cell death analysis 
Apoptotic cell death leads to the translocation of phosphatidylserine (PS) from the inner to the 
outer side of the plasma membrane of eukaryotic cells. Annexin V is a protein with high affinity 
for PS. In the early stages of apoptosis, the cell membrane stays intact, while cells that undergo 
necrosis will lose their membrane integrity. Annexin V will therefore bind apoptotic cells. 
Measurements of annexin V binding, simultaneously with a dye exclusion test to assess the 
membrane state, will give results discriminating between apoptotic and necrotic cells [51]. 
Propidium iodide (PI) staining can be used to test the membrane state, as PI cannot penetrate 
intact cell membranes.  
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Procedure: 
 Cells and medium are and centrifuged (250 g, 4 ˚C, 10 min), washed with 0.5 mL PBS 
and centrifuged again. 
 100 µl of binding buffer with annexin V (20 µl/ml) and PI (20 µl/ml) is added and mixed 
with the cell pellet. (Binding buffer, annexin V and PI from Annexin V-FITC Apoptosis 
Detection Kit). Incubation for 10 min protected from light. 
 400 µl of binding buffer is added to increase the test volume  
 Annexin V and PI binding are measured on a flow cytometer 
 
3.4.2 Cell cycle analysis 
The eukaryotic cell cycle consists of four stages; G1, S, G2 and M. During S (synthesis) phase, 
the DNA is replicated. The M-phase (mitosis) is the cellular division process where the 
chromosomes are separated to produce two daughter cells. During the gap phases (G1 and G2) 
the cells grow and synthesise proteins. Through G1, S and G2 the DNA content in the cells 
therefore vary, depending on the cells progression in the cell cycle. A cell in late S phase and G2 
will have twice the amount of DNA as a cell that is growing in G1. By measuring the amount of 
DNA present in each cell, the stage in the cell cycle can be determined (fig. 9). The reagent NIM-
DAPI (4’,6-diamidino-2-phenylindole-dihyrochloride) binds to DNA and gives fluorescence that 
can be measured on a flow cytometer. The intensity of the fluorescence will then be proportional 
to the amount of DNA in the cell [52]. 
 
Figure 9. DNA histogram from Multicycle software. DNA content is measured and used to determine the stage in the cell cycle 
31 
 
Procedure: 
 Cells are washed with PBS and incubated with trypsin  
 600 µl PBS with 10 % FBS are added to the cells 
 The cell suspension is centrifuged (250 g, 4 ˚C, 10 min) and the supernatant is removed 
 100 µl citrate buffer is added and mixed with the cell pellet  
 The samples is stored for minimum 24 hours in the freezer (-20 ˚C)  
 Samples are incubated and mixed with 300 µl NIM-DAPI solution (in the dark) for 10 
minutes before analysing 
 Fluorescence are measured on a flow cytometer 
 Results are further analysed in Multicycle software 
 
3.4.3 Measurement of glutathione (GSH) 
Glutathione (GSH) concentration in cells can be measured by flow cytometry using the reagent 
monobromobimane [53]. Monobromobimane pass through cell membranes and bind to the 
sulfhydryl (SH) group in GSH, forming fluorescent adducts. GSH level in the cells can then be 
assessed by measuring the fluorescence with a flow cytometer. Background fluorescence was 
determined by measuring the fluorescence of cells depleted of GSH after incubation with N-Ethyl 
maleimide (NEM).  
 
Procedure: 
 Cells are washed with PBS and treated with trypsin 
 400 µl PBS with 10 % FBS and 40 µM monobromobimane is added to the cells 
 15 min incubation protected from light (room temperature) 
 Fluorescence is measured on a flow cytometer  
 Results are adjusted according to background fluorescence (NEM treated cells), and 
presented as present of control  
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3.4.4 Measurement of reactive oxygen species (ROS) 
The amount reactive oxygen species (ROS) in cells can be measured on a flow cytometer using 
the reagent DCFH-DA (2,7-dichlorodihydrofluorescein diacetate). Cellular esterases convert 
DCFH-DA to the polar molecule DCFH that is further oxidized to DCF by intracellular ROS. 
DCF gives fluorescence that can be detected using a flow cytometer. The level of DCF in the 
cells will be proportional to the amount of ROS [54]. 
 
Procedure: 
 Cells are incubated with 10 µl DCFH-DA (20 µM) the last 15 minutes of the exposure 
time 
 The cells are treated with trypsin and harvested using 400 µl PBS with 10 % FBS 
 Fluorescence is measured on a flow cytometer 
 Fluorescence in control cells is set to 100 % and the amount of ROS in the exposed cells 
is calculated as percent of control 
 
3.5 Western blotting 
 
Western blotting is a comprehensive technique used to detect and quantify proteins. It is well 
explained in literature and an important technique in cell biology [50, 55, 56]. Proteins are 
extracted from cells and separated based on molecular weight through gel electrophoresis. Gel 
electrophoresis uses an electric field to arrange proteins according to their size; the smaller the 
proteins are the longer they will travel through the pores in the gel. By loading a protein marker 
in the gel, the molecular weight of the proteins can be determined. After separation on the gel, the 
proteins are transferred to and immobilized on a nitrocellulose membrane. The transfer is done 
using an electric field; the negatively charged proteins will move towards the positive field, were 
the nitrocellulose membrane is placed. The membrane is treated with 5 % bovine serum albumin 
(BSA) to prevent nonspecific binding of antibody. Further, it is incubated with a primary 
antibody specific to the protein in question, then with a secondary antibody that binds to the 
primary antibody and allows visualization of the proteins (fig. 10).  
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Figure 10. Illustration of how proteins are detected by the use of antibodies and fluorescent label in western blotting 
 
Procedure: 
 Cells are washed with PBS and harvested using a cell scrape and 130 µl sample buffer  
 15 µl of each sample (total protein of 30 µg) is electrophoresed and blotted onto a 
nitrocellulose membrane 
 Membrane is stained with Ponceau S for loading control 
 The membrane is blocked in 5 % BSA in TBS-T (TRIS-buffered saline with 0.1 % 
Tween) for 20 minutes 
 Incubation with primary antibody diluted (1:2500)  in 1 % BSA in TBS-T at 8 ˚C 
overnight 
 The membrane is washed three times (15 min) in TBS-T 
 Incubation with secondary antibody diluted (1:10 000) in 1 % BSA in TBS-T for 2 hours 
at room temperature 
 Membranes are scanned and the results analysed in Image Studio software 
 
3.6 Statistics 
 
P-values are calculated using a student t-test in Microsoft Office Excel; p < 0.05 are considered 
significant. Graphs are made in Graph Pad prism 4. 
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4 Results 
 
4.1 Cell viability 
 
The MTT assay measures SDH-activity and was used to estimate cell viability after 24 hours of 
exposure to GDMA and HEMA. Significant reduction in cell viability was observed after 
exposure to concentrations equal to or higher than 0.2 mM GDMA and 4 mM HEMA.   
 
Figure 11. Cell viability in BEAS-2B cells after 24 hours of exposure to GDMA and HEMA, estimated by succinate–
dehydrogenase (SDH)-activity. Control level was set to 100 %. The results are shown as mean ± S.D and N = 4. * indicates 
significant change from control (p < 0.05). 
 
4.2 Cell death 
Fluorescence microscopy of cells stained with Hoechst 33342 and propidium iodide (PI) was 
used to evaluate apoptosis and necrosis after 24 hours of exposure.  
GDMA exposed cells showed significant apoptosis at 0.2 mM (1.3 ± 0.3 %) and 0.4 mM (2.7 ± 
0.8 %) compared to control (0.5 ± 0.5 %). The highest concentrations of GDMA (0.8 mM and 1 
mM) showed an increase in both apoptotic and necrotic cells, but the results were not significant.  
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Exposure to 4 mM HEMA gave a significant increase in apoptotic cells (2.2 ± 1 %), while 8 mM 
HEMA gave a significant increase in both apoptotic- (4.6 ± 0.8 %) and necrotic cells (9.2 ± 
3.2 %) compared to control (0.5 ± 0.5 %) and (2 ± 1.7 %) respectively.    
 
Figure 12. Apoptosis (a) and necrosis (c) induced in BEAS-2B cells after 24 hours of exposure to GDMA and HEMA, evaluated 
by fluorescence microscopy of cells stained with Hoechst 33342 and PI. Representative pictures from microscopy of an apoptotic 
cell (b) and a necrotic cell (d) are shown. Results are presented as mean ± S.D. and N = 4. * indicates significant change from 
control (p < 0.05). 
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Flow cytometric analysis of cells stained with annexin V and PI was used to evaluate apoptosis 
and necrosis after 24 hours of exposure to GDMA and HEMA. Significant apoptosis was 
observed after exposure to 0.4 mM GDMA (10.1 ± 1.4 %) compared to control (6 ± 2.8 %). No 
significant necrosis was seen following GDMA exposure. After HEMA exposure, there was no 
significant increase in apoptotic- or necrotic cell.  
 
 
Figure 13. Apoptosis (a) and necrosis (b) in BEAS-2B cells induced by 24 hours of exposure to GDMA and HEMA, measured by 
flow cytometry of cells stained with annexin V and PI. The results are shown as mean ± S.D. and N ≥ 3. * indicates significant 
change from control (p < 0.05). 
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4.3 Glutathione (GSH) 
Flow cytometric analysis of monobromobimane treated cells was used as a measurement of the 
GSH levels in cells after 24 hours of exposure to GDMA, HEMA, DEM and BSO.  
GSH levels in cells exposed to 0.4 mM GDMA were significantly lower than control (set to 
100 %) after 2 hours (22.5 ± 21 %), 6 hours (20 ± 12.9 %) and 24 hours (56.9 ± 2.9 %). 
Significantly reduced GSH levels were seen in cell exposed to 4 mM HEMA for 2 hours (25.6 ± 
18.8 %) and 6 hours (17.8 ± 33.3 %). 
Exposure to DEM gave no significant reduction in GSH levels, but after 24 hours, a significant 
increase was seen with all the concentrations tested. BSO reduced the level of GSH after 6 hours 
of exposure to - 0.01 mM (82.6 ± 4 %) and 0.025 mM (84.1 ± 3.6 %). A further reduction was 
seen after 24 hours, but the results were not significant.      
 
Figure 14. GSH levels in BEAS-2B cells after 2,6 and 24 hours of exposure to GDMA (a), HEMA (b), DEM (c) and BSO (d). 
The results are shown as mean ± S.D and N ≥ 3. Control level is set to 100 %. * indicates significant change from control (p < 
0.05).   
38 
 
4.4 Reactive oxygen species (ROS) 
Flow cytometric analysis of cells treated with DCFH-DA was used to measure ROS levels in 
cells after 24 hours of exposure to GDMA, HEMA, DEM and BSO.  
ROS levels in cells exposed to GDMA were higher than control (set to 100 %), although not 
significant, after 2 hours. After 6 hours a significant increase in ROS was measured in cells 
exposed to 0.2 mM (121.2 ± 4.1 %) and 0.4 mM (124.1 ± 3.2 %) GDMA.  
HEMA induced significant increase in ROS levels after 2 hours of exposure to 2 mM (140.3 ± 
10.3 %) and 4 mM (144.8 ± 19 %). Significant increase in ROS levels was also seen 6 hours after 
exposure to 2 mM HEMA (119.8 ± 2.5 %). 
No significant increase in ROS levels were seen after exposure to DEM. After 24 hours, a 
significant decrease was observed in cells exposed to 0.025 mM (69.1 ± 9.9 %) and 0.05 mM 
(74.2 ± 6 %) DEM. Cells exposed to BSO showed no significant change in ROS levels. An 
increase was observed after 6 hours, but the results were not significant.  
 
Figure 15. ROS levels in BEAS-2B cells after 2,6 and 24 hours of exposure to GDMA (a), HEMA (b), DEM (c) and BSO (d). 
The results are shown as mean ± S.D and N = 3. Control level is set to 100 %. * indicates significant change from control (p < 
0.05).  
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4.5 Cell cycle 
Flow cytometric measurements of DNA contents were used to analyse cell cycle progression in 
cells exposed 24 hours to GDMA, HEMA, DEM and BSO.  
Significant increase in the percentage of cells in S-phase was observed after exposure to both 
GDMA and HEMA. Compared to control (32.7 ± 3.2 %) the percentage of cells in S-phase 
increased to 39.7 ± 5.7 % after exposure to 0.4 mM GDMA and 52 ± 4.6 % after exposure to 4 
mM HEMA. Histograms of cell cycle distribution show that HEMA induces an accumulation of 
cells in early S-phase, while GDMA exposed cells are evenly distributed throughout S-phase. 
 
 
Figure 16. Percentage of BEAS-2B cells in G1-, S- and G2-phase after 24 hours of exposure to GDMA (a) and HEMA (b). The 
results are shown as mean ± S.D. and N ≥ 5. * indicates significant change from the control (p < 0.05). Representative histograms 
are shown for control (c), 0.4 mM GDMA (d) and 4 mM HEMA (e). 
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Exposure to diethyl maleate (DEM) and buthionine sulfoximine (BSO) induced no significant 
change in the percentage of cells in any of the phases of the cell cycle. No apparent change was 
seen in the histograms (data not shown).  
 
Figure 17. Percentage of BEAS-2B cells in G1-, S- and G2-phase after 24 hours of exposure to DEM (a) and BSO (b). The 
results are shown as mean ± S.D. and N = 3. 
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4.5.1 Cell cycle regulatory proteins 
Western blotting was used as a technique to measure cyclin E1 and cyclin D1 levels in cells 
exposed 24 hours to GDMA and HEMA. β-actin and Ponceau S were used as loading controls, 
and showed even distribution of proteins in each lane of each experiment (data not shown).   
Cells exposed to 0.4 mM GDMA showed significantly lower levels of cyclin E1 (57 ± 20 %) and 
cyclin D1 (6 ± 5 %) compared to control (set to 100 %). Exposure to 1 mM HEMA significantly 
increased the level of cyclin E1 (133.8 ± 31.6 %) and 4 mM of HEMA decreased the level of 
cyclin D1 (44 ± 22 %). 
 
Figure 18. Cyclin E1 (a) and Cyclin D1 (b) levels in BEAS-2B cells after 24 hours of exposure to GDMA and HEMA. 
Representative blots are shown below. The results are shown as mean ± S.D and N ≥ 5. Dotted line illustrates the control levels 
(set to 100%). * indicates significant change from control (p < 0.05). β-actin and ponceau S were used as loading controls.  
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4.6 DNA damage response signalling proteins 
Western blotting was used as a technique to measure levels of the DNA damage response 
signalling proteins pP53, γH2AX and pChk2 in cells after 24 hours of exposure to GDMA and 
HEMA. Β-actin and Ponceau S were used as loading controls, and showed even distribution of 
proteins in each lane of each experiment (data not shown).   
 
4.6.1 pP53 
No change in pP53 levels were seen in cells exposed to GDMA. After exposure to HEMA, a 
significant increase in pP53 levels were seen at 4 mM (175.5 ± 26.7 %) compared to control (set 
to 100 %).  
 
Figure 19. pP53 levels in BEAS-2B cells exposed 24 hours to GDMA and HEMA. The results are shown as mean ± S.D and N = 
4. Dotted line illustrates control level (set to 100 %). A representative blot is shown below. * indicates significant change from 
control (p < 0.05). β-actin and ponceau S were used as loading controls.  
 
4.6.2 γH2AX 
Cells exposed to 0.4 mM GDMA showed a significant increase in γH2AX levels (213.3 ± 
49.6 %) compared to control (set to 100 %). No change in γH2AX levels were seen in cells after 
HEMA exposure.   
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Figure 20. γH2AX levels in BEAS-2B cells exposed 24 hours to GDMA and HEMA. The results are shown as mean ± S.D and N 
= 4. Dotted line illustrates control level (set to 100 %). A representative blot is shown below. * indicates significant change from 
control (p < 0.05). β-actin and ponceau S were used as loading controls.  
 
4.6.3 pCHk2 
No change in pChk2 levels were seen in cells exposed to GDMA or HEMA. All the experiments 
gave however a level of pChk2 that was higher than control in the cells exposed to 4 mM HEMA 
(112 – 426 % of the control, N = 5). This was not seen after GDMA exposure. 
 
Figure 21. pChk2 levels in BEAS-2B cells exposed 24 hours to GDMA and HEMA. The results are shown as mean ± S.D and N 
= 5. Dotted line illustrates control level (set to 100 %). A representative blot is shown below. β-actin and ponceau S were used as 
loading controls.  
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5 Discussion 
 
An in vitro model system was used in the present study to investigate and compare the cellular 
mechanisms following exposure to the methacrylate monomers GDMA and HEMA. The role of 
glutathione depletion in monomer induced cell growth disturbance was investigated comparing 
the effects of monomers to DEM and BSO exposure. DEM and BSO, two well-known 
glutathione depleting agents. By measuring levels of cyclins (D1 and E1) and activation of p53, 
H2AX and Chk2, the DNA damage response-signalling pathways were compared between the 
monomers.  
 
5.1 Methodological considerations 
 
Methacrylate monomers are found to be airborne in dental practices [15, 16], making airway 
exposure likely. Hence, BEAS-2B cells (bronchial epithelial cells) are a relevant model for 
studying methacrylate effects. BEAS-2B cells are commercially available and often used as an in 
vitro model for testing inhalation toxicity [41, 57, 58]. In general, immortalized cell lines are 
stable model systems, easy to work with and cost-effective. Therefore, these model systems are 
important in toxicology studies focusing on cellular response mechanisms. It is, however, 
important to be aware of limitations associated with an in vitro approach compared to the in vivo 
situation. Cell lines are homogenous and cannot mimic the complexity of an organism where 
multiple cells and factors constantly interact. In addition, cell lines have altered properties 
compared to their in vivo counterpart. Based on this, extrapolation from in vitro studies to the in 
vivo situation must be done with caution. In vitro systems are, however, clearly valuable in early 
cellular response studies that may form the basis for further in vivo research [59].  
The monomer concentrations used in this study are relatively high compared to concentrations 
measured in salvia of patients after treatments [13, 17, 60] and in the air of dental practices [15, 
16]. However, the exposure period in a clinical situation is extended compared to what is 
achievable in an in vitro system. To induce cellular responses in vitro, higher concentrations are 
45 
 
needed. The exposure concentrations chosen are below the level where extensive cell death are 
induced, to avoid interfering signalling from DNA degradation during cell death [61].  
Cell viability was estimated using the MTT assay, which actually measures the SDH-enzyme 
activity in mitochondria [45]. This activity can be reduced due to cell death, but also reduced 
proliferation and impaired mitochondrial activity. The MTT assay was therefore supplemented 
with fluorescence microscopy and flow cytometry to detect cell death and changes in cell 
proliferation. Fluorescence microscopy allows visual detection of apoptotic and necrotic cells. 
The relatively low number of cells that can be assessed with this method is, however, a 
disadvantage. Flow cytometry lack the advantage of visualization, but allows a large amount of 
individual cells to be analysed quickly and with high precision [20]. In combination, these 
methods provide a thorough assessment of cytotoxicity.  
Western blotting was used to detect and quantify protein levels. The use of loading controls 
verifies even amounts of protein in each sample. Through electrophoresis, the proteins are 
separated based on molecular weight. This will prohibit that unspecific binding of antibodies 
interferes with the results, which can be a weakness of other immunoassays such as ELISA. 
Western blotting has been considered “semi-quantitative” due to limitations in the detection step. 
This limitation has been eliminated due to the use of direct scanning and imaging software, which 
provides a much wider linear dynamic range compared to the classical techniques.  
 
5.2 Discussion of results 
 
Both GDMA and HEMA reduced the number of viable BEAS-2B cells in a concentration-
dependent manner. Increased apoptotic cell death and induced changes in the cell growth pattern 
were observed, in line with previous findings [35, 36, 38, 39, 41, 62]. The aim of this study was, 
however, to elucidate differences in cellular response mechanisms. GDMA appeared to be more 
potent than HEMA, as a lower concentration of GDMA was needed to significantly reduce cell 
viability. This difference is also observed in previous findings [10, 35]. A 10-fold difference in 
potency to induce cell death was observed between GDMA and HEMA. Therefore, when 
comparing cellular response mechanisms 0.4 mM GDMA were compared to 4 mM HEMA.  
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In line with other studies, GDMA and HEMA induced changes in the cell growth pattern [38, 39, 
41, 62]. However, appearance of the cell cycle histograms differs between the two methacrylates. 
HEMA exposed cells show accumulation in early S-phase. In contrast, the increase after GDMA 
exposure was evenly distributed throughout the S-phase. Stalled cell cycle progression allows 
activation of DNA damage repair, protecting cells from copying damaged DNA [63, 64]. The 
observed effects on cell cycle distribution could therefore be caused by DNA damage and 
activation of repair mechanisms induced by GDMA and HEMA. In addition to inducing 
accumulation of cells in S-phase, GDMA and HEMA significantly changed cyclin levels in 
BEAS-2B cells. Cyclins in complex with cyclin-dependent kinases (CDKs) are essential in 
regulating the progression through the cell cycle. GDMA and HEMA had different effects on 
cyclin levels in BEAS-2B cells. Cyclin D1 levels were reduced after exposure to both monomers. 
Levels of cyclin E1 on the other hand, were reduced by GDMA, but not by HEMA. Interestingly, 
the lowest concentration of HEMA increased the cyclin E1 levels. Overexpression of these 
cyclins are associated with accelerated entry into S-phase [65]. Cyclin D1 and E1 are involved in 
phosphorylation of the retinoblastoma protein (Rb) and activation the transcription factor E2F, 
initiating DNA synthesis [66]. Hence, down regulation of cyclins can possibly delay the entry 
into and the progression through S-phase, due to inhibition of DNA synthesis.    
Taken together, the effects on cell cycle distribution and cyclin levels support involvement of 
DNA damage. However, the mechanisms seem to differ between GDMA and HEMA.  
Activation of DNA damage signalling proteins in BEAS-2B cells indicates induction of DNA 
damage by both GDMA and HEMA. DNA double strand breaks (DSBs) are detected by the 
protein kinase ATM, which further activates other signalling proteins, including H2AX and Chk2 
[27, 30, 67]. The phosphorylation of H2AX is established as a specific and sensitive molecular 
marker of DSBs [68]. The DNA damage response caused by HEMA is suggested to involve P53, 
H2AX and Chk2 [36, 39, 41]. The complex role of p53 in cell signalling makes simplification of 
its role difficult, but DNA damage is one of the stressors able to activate p53 [20]. Both cell cycle 
arrest and apoptosis are possible endpoints in p53 signalling pathways [69]. In the current study, 
HEMA increased activation of P53 and Chk2, but not H2AX. GDMA induced activation of 
H2AX, but not p53 or Chk2. GDMA is previously shown to induce DSBs in vitro, determined by 
the γH2AX assay [70]. DSBs caused by the apoptotic process are also able to activate H2AX 
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[61]. However, the lack of H2AX activation in cells exposed to 4 mM HEMA suggests that DSBs 
are due to direct DNA damage. Activation of Chk2 by GDMA and H2AX by HEMA cannot be 
excluded, as the measurements were conducted at only one time point. Previous studies have 
measured H2AX activation after HEMA exposure [41].  
DNA damage caused by methacrylate monomers is suggested, at least in part, to be a result of 
oxidative stress [36, 71]. Depletion of glutathione (GSH) and an increase in reactive oxygen 
species (ROS) is a well-documented response to methacrylate monomers [36]. HEMA induced 
cell death was increased when cells were GSH-depleted prior to HEMA exposure, illustrating the 
importance of GSH for cellular defence [42]. In the current study, comparable concentrations of 
GDMA and HEMA induced similar oxidative stress response in BEAS-2B cells. However, 
growth patterns were affected differently, suggesting involvement of additional mechanisms. 
DEM and BSO were included to investigate if the cell cycle disturbance after monomer exposure 
could be explained by GSH depletion and oxidative stress. Reduction of GSH levels were seen 
six- and twenty-four hours after BSO exposure in BEAS-2B cells, while DEM did not induce 
detectable GSH-depletion. The cells respond to DEM exposure by increasing its GSH-
production. This could indicate adaption to GSH-depletion not detectable by the method used in 
the current study. In other cell lines, reduction of cell proliferation is previously implied for both 
DEM [72] and BSO [73]. DEM is believed to deplete nuclear GSH [72], while BSO inhibits GSH 
synthesis [74]. Nuclear GSH could therefore be important in cell cycle progression as DEM, and 
not BSO, led to impaired cell proliferation of 3T3 fibroblasts [72]. In the current study, however, 
cell growth disturbance could not be observed after exposure to DEM and BSO. Overall, this 
indicate different involvement of GSH in growth regulation in different cell lines.  
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6 Conclusions 
 
In the current study, GDMA and HEMA induced cytotoxic responses in BEAS-2B cells. Similar 
changes in GSH and ROS levels were observed after exposure to both monomers. Evidence of 
DNA damage was also observed, but the DNA damage response differed between the two 
monomers. Hence, GSH-depletion and ROS increase alone cannot explain methacrylate induced 
toxicity in BEAS-2B cells. 
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Future perspectives 
 
The work presented in this thesis show involvement of different mechanisms in the in vitro 
methacrylate induced DNA damage response. This raises questions relevant for future studies. 
Studies on other DNA damage signalling response pathways would be valuable, especially 
related to GDMA induced genotoxicity. The signalling proteins ATR and Chk1, associated with 
single strand breaks could be relevant for future work.   
Possible effects on the retinoblastoma protein (Rb) and the transcription factor E2F could be 
interesting for further investigations of methacrylate induced cell cycle regulation. In addition, as 
nuclear GSH content were suggested relevant for cell cycle progression, it would be useful to 
obtain insights into the GSH distribution in different cellular compartments. 
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